MedPath

Evaluation of endometrial CD 138 values in infertile women and its correlation with results of early pregnancy

Not Applicable
Conditions
Health Condition 1: O269- Pregnancy related conditions, unspecified
Registration Number
CTRI/2024/04/066043
Lead Sponsor
Datta Meghe Institute of higher education and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age under 21-40 years

No history of Acute/Chronic Pelvic Inflammatory Disease

All the women willing for at least 2 cycles of advance infertility treatment will be

enrolled.

Women willing to participate in the study.

Exclusion Criteria

Intrauterine surgery, synechiae, septum, submucosal fibroid

Active vulvovaginitis

Previous surgery for endometritis

Ultrasound diagnosis of endometritis.

Previous history of Genital TB

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of CD138 in women seeking treatment of infertility, out of 60 womenTimepoint: CD 138 sample sent on Operative Day 1 of Diagnostic hysterolaproscopy
Secondary Outcome Measures
NameTimeMethod
Correlation of CD138 positivity with ß HCG , Urine pregnancy test, Clinical <br/ ><br>pregnancy, Early pregnancy outcome, Live birth (if possible within study period)Timepoint: ß HCG , will be done after 14 days after embryo transfer <br/ ><br>Urine pregnancy test done after 21 days of embryo transfer <br/ ><br>Clinical pregnancy (USG) will be done after 28 days of embryo transfer <br/ ><br> Early pregnancy outcome seen till 28 weeks of gestation age
© Copyright 2025. All Rights Reserved by MedPath